Riskpilot← Back to searchSign inGet full accessAll Molecules AB
ABActiveOrg 5593253122Reimersholmsgatan 34Wholesale of perfume and cosmetics · NACE 4645Est. 20210 employees
Revenue 2024
SEK 12K
-94% vs 2023
EBITDA margin
-13839.0%
-83% vs 2023
Equity ratio
91.2%
Financial strength
Net profit 2024
SEK -1,7M
-78% vs 2023
| Revenue | SEK 12K | -94% |
| EBITDA | SEK -1,7M | -83% |
| Net profit | SEK -1,7M | -78% |
| Total assets | SEK 731K | -48% |
| Equity | SEK 666K | -52% |
| Employees | 0 | — |
Legal name
All Molecules AB
Org number
5593253122
Legal form
Aktiebolag
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
1 juli 2021
Share capital
SEK 34 315
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska försälja och distribuera kosmetiska-, hygien-, och kosttillskottsprodukter, samt därmed förenlig verksamhet.
Address
Reimersholmsgatan 34
Email
david@tinyassociates.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Revenue | 53 | 196 | 12 |
| Staff expenses | — | — | −420 |
| EBITDA | −679 | −931 | −1 705 |
| Depreciation & amort. | — | — | — |
| EBIT | −679 | −931 | −1 705 |
| Net financials | 0 | −21 | 8 |
| Profit before tax | −679 | −952 | −1 697 |
| Tax | — | — | — |
| Net profit | −679 | −952 | −1 697 |
| Item | 2022 | 2023 | 2024 |
|---|---|---|---|
| Total assets | 2 892 | 1 406 | 731 |
| Equity | 2 839 | 1 377 | 666 |
| Long-term debt | — | — | — |
| Short-term debt | 53 | 29 | 64 |
| Total debt | 53 | 29 | 64 |
EBITDA margin
-13839.0%
This company
15.8%
Market median
-87689% vs market
20222024
Equity ratio
91.2%
This company
38.2%
Market median
+139% vs market
20222024
Return on equity
-254.8%
This company
18.4%
Market median
-1485% vs market
20222024
Net profit margin
-13772.2%
This company
8.1%
Market median
-170127% vs market
20222024
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20222024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20222024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DA Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
KM Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2021 – 2021 | |
| Board of Directors | 2021 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of All Molecules AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Maria Hjalmarsson | Chief Executive Officer | 0 companies |
| David Alexandre Hjalmarsson | Chief Executive Officer | 0 companies |
| Anders Jakob Lindquist | Deputy Board Member | 0 companies |
| Torbjörn Nordberg | Board of Directors | 0 companies |
| Karl Johan David Hjalmarsson | Deputy Board Member | 0 companies |